Alpha 2.0
Login Register
» Authors » Yoonyeong Lee

Yoonyeong Lee

Explore the profile of Yoonyeong Lee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 45
Followers 0
Related Specialties
General Medicine
Biochemistry
Biology
Top 10 Co-Authors
Jae Seung Yang
Deok Ryun Kim
T Anh Wartel
Sushant Sahastrabuddhe
Hun Kim
Jerome H Kim
Ji Hwa Ryu
Zenaida Reynoso Mojares
Edison Alberto
Tarun Saluja
Published In
Bioorg Med Chem Lett
Lancet Infect Dis
Vaccine
Mar Drugs
NPJ Vaccines
Affiliations
Soon will be listed here.
Recent Articles
1.
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants
Saluja T, Rai G, Chaudhary S, Kanodia P, Giri B, Kim D, et al.
Vaccine . 2022 Sep; 40(40):5828-5834. PMID: 36064672
Background: Typhoid fever is a common disease in developing countries especially in the Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been found to be highly immunogenic...
2.
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
Carlos J, Tadesse B, Borja-Tabora C, Alberto E, Ylade M, Sil A, et al.
Lancet Reg Health West Pac . 2022 Jun; 24:100484. PMID: 35664443
Trial Design: Phase 3, randomized, controlled, multicenter, equivalence trial. Methods: Recruitment of participants occurred between 04Februray2020 and 15July2020 at four centers in the Philippines: University of the East - Ramon...
3.
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose
Capeding M, Tadesse B, Sil A, Alberto E, Kim D, Park E, et al.
NPJ Vaccines . 2022 Jan; 7(1):12. PMID: 35087084
Vaccination with typhoid conjugate vaccines (TCV) is a major part of typhoid prevention. However, little is known about long-term immune persistence following vaccination with TCVs. In this phase-2, randomized double-blind...
4.
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
Rai G, Saluja T, Chaudhary S, Tamrakar D, Kanodia P, Giri B, et al.
Lancet Infect Dis . 2021 Dec; 22(4):529-540. PMID: 34942090
Background: Typhoid fever is an endemic disease in many low-income and middle-income countries. The 2018 WHO position paper recommends that countries should consider typhoid vaccination in high-risk groups and for...
5.
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
Capeding M, Sil A, Tadesse B, Saluja T, Teshome S, Alberto E, et al.
EClinicalMedicine . 2020 Nov; 27:100540. PMID: 33150320
Background: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for young...
6.
Cyclic Bis-1,3-dialkylpyridiniums from the sponge Haliclona sp
Lee Y, Jang K, Jeon J, Yang W, Sim C, Oh K, et al.
Mar Drugs . 2012 Nov; 10(9):2126-2137. PMID: 23118726
Eight novel cyclic bis-1,3-dialkylpyridiniums, as well as two known compounds from the cyclostellettamine class, were isolated from the sponge Haliclona sp. from Korea. Structures of these novel compounds were determined...
7.
Bioactive lipids from the sponge Spirastrella abata
Jang K, Lee Y, Sim C, Oh K, Shin J
Bioorg Med Chem Lett . 2011 Dec; 22(2):1078-81. PMID: 22182501
Three sphingosine 4-sulfates (1-3) and a lysophosphatidylglycerol (4) were isolated from the Korean sponge Spirastrella abata. The structures of these compounds were determined based on the combined results of spectroscopic...